 - Possible association between the primary and secondary outcomes and specific immunological endpoints including levels of circulating CD4 and CD8 T lymphocytes, T-cell proliferation response, cytotoxic T lymphocyte CTL response, and development of antibodies to prostate-specific antigens. 